These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26800492)

  • 1. Characterization of patients at high risk of melanoma in Austria.
    Müller C; Wendt J; Rauscher S; Burgstaller-Muehlbacher S; Sunder-Plassmann R; Scheurecker C; Richtig E; Fae I; Fischer G; Pehamberger H; Okamoto I
    Br J Dermatol; 2016 Jun; 174(6):1308-17. PubMed ID: 26800492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
    Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors of Subsequent Primary Melanomas in Austria.
    Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CDKN2A mutations in Austrian melanoma patients.
    Burgstaller-Muehlbacher S; Marko M; Müller C; Wendt J; Pehamberger H; Okamoto I
    Melanoma Res; 2015 Oct; 25(5):412-20. PubMed ID: 26225579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
    Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
    J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
    Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
    Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter case-control study of risk factors for cutaneous melanoma in Valencia, Spain.
    Ballester I; Oliver V; Bañuls J; Moragón M; Valcuende F; Botella-Estrada R; Nagore E
    Actas Dermosifiliogr; 2012 Nov; 103(9):790-7. PubMed ID: 22626452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
    Cust AE; Goumas C; Vuong K; Davies JR; Barrett JH; Holland EA; Schmid H; Agha-Hamilton C; Armstrong BK; Kefford RF; Aitken JF; Giles GG; Bishop D; Newton-Bishop JA; Hopper JL; Mann GJ; Jenkins MA
    BMC Cancer; 2013 Sep; 13():406. PubMed ID: 24134749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
    Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
    BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
    Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
    Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of malignant melanoma--lessons to be learned from Austria.
    Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
    Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
    Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
    Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
    Hacker E; Nagore E; Cerroni L; Woods SL; Hayward NK; Chapman B; Montgomery GW; Soyer HP; Whiteman DC
    J Invest Dermatol; 2013 Apr; 133(4):1027-33. PubMed ID: 23096702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.